エストロゲンとプロゲスチンの併用および冠状動脈性心疾患のリスク

Manson ら（木曜日）はこの問題を研究しました。

www.synapsesocial.com/papers/69deddfe488ed2d92be9423e — DOI: https://doi.org/10.1056/nejmoa030808

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Subgroup Interactions in the Heart and Estrogen/Progestin Replacement Study· 2002 · 75 citations
2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial· 1995 · 605 citations
3. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. <i>JAMA</i> 2002; 288(3): 321-333· 2002 · 1,179 citations
4. Medical Research Laboratories· 2004 · 8 citations
5. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial· 2002 · 330 citations